Pharmacological Characterization of a Primary Nicotinic Receptor from the Neuromuscular Junction
Thursday May 26th. 11am Eastern, 12pm Central, 10am Pacific
Speakers: Andrew Cook, Senior Study Director, Eurofins Discovery Services
At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Thursday May 26th. 11am Eastern, 12pm Central, 10am Pacific
Speakers: Andrew Cook, Senior Study Director, Eurofins Discovery Services
Speaker: Dr. Andrew Jenkins Ph.D, Associate Professor, Faculty of Pharmacy & Pharmaceutical Sciences, Emory University School of Medicine
Speaker: Dr. Claudia Vuotto, PhD, Team Leader at Microbial Biofilm Laboratory, Fondazione Santa Lucia IRCCS
Speaker: Dr. Khaled Barakat PhD, Assistant Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta
Speaker: Dr. Haiyang Wei, PhD, Director of Drug Discovery Partnerships, Eurofins Discovery
Speakers: María Jose Serrano, PhD, Hospital Universitario Virgen de las Nieves, and Rocio Ramos-Medina, PhD, Hospital General Universitario Gregorio Marañón
Speakers: Jeff Jensen, CEO, Fluxion Biosciences
Speaker: Ali Yehia PhD, Fluxion Biosciences
Speaker: Péter Lukács, Centre for Agricultural Research, Eötvös Loránd University, Department of Biochemistry
Speaker:Dr. Giordano Pula, PhD, Group Leader for Haemostasis and Thrombosis, University Medical Center Eppendorf, University of Hamburg